START LOW: topical retinoids are available in both over the counter and prescription strengths. Here's the order of strength:
OTC: retinol < retinal/retinaldehyde < adapalene 0.1%
Prescription: tretinoin 0.025% < tretinoin 0.05% < tretinoin 0.1% < tazarotene 0.1%
A great update on the guidelines for VTE prophylaxis & treatment 🩸 🛑 💊 in cancer patients. Recommendations posted and now it’s time for guideline implementation.
@NicoleKuderer@aakonc@JCO_ASCO@OncoAlert@ASCO#ASCO23 https://t.co/bYFlLzH5h3
The goal of the ACTIVE-AF trial was to assess the safety and efficacy of exercise and physical activity intervention among patients with symptomatic paroxysmal or persistent #AFib. Get the clinical trial details here:
The goal of the CLEAR Outcomes trial was to compare the safety and efficacy of bempedoic acid compared with placebo among patients with or at high risk for CVD and were intolerant of statin therapy. Read more: https://t.co/hVVylN3Lyy #ACC23/#WCCardio
We are happy to announce the opening of the two ILMA-KU post-doc research applications. We are looking forward to selecting at least two new Lebanese medical graduates for our 2023-2024 post-doc program in partnership with KU. @usa_ilma@KUSM_Wichita https://t.co/bJQyT615js
During my Internal Medicine training, I wrote 100s of discharge (d/c) summaries.
In my PGY4 chief year, I was an outpatient attending and reviewed many d/c summaries.
Here are some tips and tricks for your d/c summaries.
-thread 🧵-
#MedTwitter#MedEd#Cardiotwitter#IMG
I'm begging healthcare workers to stop sharing stories about what a patient said or did, even if no identifying information is given. It's not just a matter of privacy but a matter of respect. I expect my doctor or nurse to not tweet about *my* experience just for likes.